ZA200602143B - Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same - Google Patents

Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same Download PDF

Info

Publication number
ZA200602143B
ZA200602143B ZA200602143A ZA200602143A ZA200602143B ZA 200602143 B ZA200602143 B ZA 200602143B ZA 200602143 A ZA200602143 A ZA 200602143A ZA 200602143 A ZA200602143 A ZA 200602143A ZA 200602143 B ZA200602143 B ZA 200602143B
Authority
ZA
South Africa
Prior art keywords
extract
mahonia aquifolium
mixture
mahonia
aquifolium
Prior art date
Application number
ZA200602143A
Other languages
English (en)
Inventor
Mills Robert
Mathur Rajiv
Lawrence Nadya
Original Assignee
Prime Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prime Pharmaceutical Corp filed Critical Prime Pharmaceutical Corp
Publication of ZA200602143B publication Critical patent/ZA200602143B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
ZA200602143A 2003-09-25 2004-09-22 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same ZA200602143B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/669,416 US7205006B2 (en) 2003-09-25 2003-09-25 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

Publications (1)

Publication Number Publication Date
ZA200602143B true ZA200602143B (en) 2007-09-26

Family

ID=34375887

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200602143A ZA200602143B (en) 2003-09-25 2004-09-22 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

Country Status (16)

Country Link
US (2) US7205006B2 (fr)
EP (1) EP1663154B1 (fr)
JP (1) JP2007506685A (fr)
KR (1) KR20060069514A (fr)
CN (1) CN1856318B (fr)
AT (1) ATE488226T1 (fr)
AU (1) AU2004273556B2 (fr)
BR (1) BRPI0414786A (fr)
CA (1) CA2538867A1 (fr)
DE (1) DE602004030131D1 (fr)
IL (1) IL174206A (fr)
MX (1) MXPA06003146A (fr)
NZ (1) NZ545853A (fr)
RU (1) RU2388482C2 (fr)
WO (1) WO2005027945A1 (fr)
ZA (1) ZA200602143B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
CA2876767C (fr) * 2005-10-03 2018-07-10 Mark A. Pinsky Liposomes contenant de l'acide hyaluronique et leur utilisation dans l'amelioration des soins de la peau
ES2599630T3 (es) * 2006-09-28 2017-02-02 Hadasit Medical Research Services & Development Limited Uso de glicerofosfolípidos para lubricación de las articulaciones
WO2011000218A1 (fr) * 2009-06-30 2011-01-06 Shuen-Lu Huang Compositions contenant de la berbérine ou des analogues de celle-ci pour traiter l’acné rosacée ou des troubles cutanés associés à une rougeur faciale
DE202010004750U1 (de) 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
BR112012032153A2 (pt) * 2010-06-17 2017-08-08 Yeda Res And Development Company Ltd método para a lubrificação de uma ou mais superfícies não biológicas, método para a lubrificação de uma ou mais superfícies de um tecido biológico em um indivíduo mamífero, uso de lipossomas na fase em gel e lipossoma misto
DE102010030443A1 (de) * 2010-06-23 2011-01-05 Lr Health & Beauty Systems Gmbh Kosmetische Zusammensetzung und deren Verwendung
EP3313520A4 (fr) * 2015-06-24 2019-01-02 TWI Biotechnology, Inc. Utilisations thérapeutiques de formulations de berbérine
GB2561818B (en) 2017-03-30 2020-01-15 Phyto Sophos Ltd Plant extract compositions
CN111065423B (zh) 2017-08-22 2022-04-12 莫比斯医疗有限公司 用于关节润滑的脂质体制剂
JP6535146B1 (ja) * 2019-03-08 2019-06-26 佐藤製薬株式会社 皮膚バリア機能改善剤
EP4522178A1 (fr) 2023-01-19 2025-03-19 Moebius Medical Ltd. Composition liposomale à action prolongée pour le traitement de la douleur dans des troubles articulaires

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US216317A (en) * 1879-06-10 Improvement in medical compounds
US3882244A (en) 1971-12-13 1975-05-06 Univ California Method of treating acne with a c{hd 20 {b acid
US4054589A (en) 1974-09-26 1977-10-18 Hoffmann-La Roche Inc. Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters
US4215215A (en) 1975-08-01 1980-07-29 Hoffmann-La Roche Inc. 9-Phenyl-nonate traene compounds
US4105681A (en) 1975-08-01 1978-08-08 Hoffmann-La Roche Inc. 9-phenyl 5,6-dimethyl-nona-2,4,6,8-tetraeonic acid compounds
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
JPS5738388Y2 (fr) * 1979-09-03 1982-08-24
SU931186A1 (ru) * 1979-12-19 1982-05-30 Пятигорский фармацевтический институт Способ получени берберина бисульфата
US4476056A (en) 1982-11-05 1984-10-09 Hoffmann-La Roche Inc. Trifluoromethoxy analogs of aromatic retinoids
US4818533A (en) 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
US4866048A (en) 1985-08-02 1989-09-12 Leo Pharmaceutical Products Ltd. Novel vitamin D analogues
US4837378A (en) 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US4713394A (en) 1986-01-17 1987-12-15 Thornfeldt Carl R Treatment of nonacne inflammatory and infectious dermatoses and hair loss
US4767861A (en) 1986-01-28 1988-08-30 Vipont Laboratories Recovery of benzo-c-phenanthridine alkaloids
US4865048A (en) * 1987-12-31 1989-09-12 Eckerson Harold D Method and apparatus for drug free neurostimulation
JPH0390022A (ja) * 1989-08-31 1991-04-16 Mochida Pharmaceut Co Ltd 皮膚疾患治療用外用剤
GB9004544D0 (en) 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
FR2673840A1 (fr) * 1991-03-14 1992-09-18 Lvmh Rech Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant de l'oxyacanthine, en particulier destinee a stimuler la pousse des cheveux ou a retarder leur chute.
FR2684300B1 (fr) 1991-11-29 1994-03-11 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee en particulier a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de ballote, et son procede de fabrication.
FR2699081B1 (fr) * 1992-12-11 1995-04-07 Lvmh Rech Utilisation d'un extrait de Simaba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue.
FR2699080B1 (fr) * 1992-12-11 1995-04-07 Lvmh Rech Utilisation d'un extrait de Simarouba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue.
CN1102993A (zh) 1993-12-21 1995-05-31 吴文才 多酶体系加工中草药的制剂方法
FR2722098B1 (fr) 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
CN2203180Y (zh) * 1994-08-22 1995-07-12 张仁忠 多功能提取罐
PL188137B1 (pl) * 1995-02-03 2004-12-31 Aeterna Lab Inc Zastosowanie wyciągu z chrząstki rekina
WO1996028156A1 (fr) * 1995-03-13 1996-09-19 Eli Lilly And Company Methodes et composes nouveaux de benzothiophene
US6271001B1 (en) 1995-03-23 2001-08-07 Bio Polymers Pty. Ltd. Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications
FR2734265B1 (fr) * 1995-05-17 1997-06-13 Adir Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
US5856487A (en) 1996-02-14 1999-01-05 National Institute Of Immunology Application of protoberberine alkaloid, berberine, an immunosuppressive agent
EP0892638B1 (fr) * 1996-04-04 2002-11-13 Cilag AG Formulation topique de vitamine d a base de liposomes
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
US6048902A (en) 1999-02-12 2000-04-11 Lebwohl; Mark G. Short contact treatment of psoriasis with topical retinoids
US6210680B1 (en) 1999-06-11 2001-04-03 Univera Pharmaceuticals, Inc. Method for the prevention and treatment of chronic venous insufficiency
US6238696B1 (en) 2000-01-07 2001-05-29 Gaia Herbs, Inc. Process for providing herbal medicants in cellulose derivative capsules
US6440465B1 (en) 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US6254896B1 (en) 2000-05-17 2001-07-03 Brent W. Davis Apparatus and process for in situ manufacture of essence from living, uncut plants
DE20109044U1 (de) 2001-05-30 2001-08-09 Weber & Weber GmbH & Co. KG, 82266 Inning Pharmazeutische Zubereitung
US20030096422A1 (en) 2001-11-16 2003-05-22 Ong Eng Shi Pressurized liquid extraction method and apparatus
US20030185915A1 (en) 2002-03-28 2003-10-02 Jaime Carlo Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor
US20040043946A1 (en) 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US7205006B2 (en) 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
AU2004273556A1 (en) 2005-03-31
IL174206A (en) 2011-03-31
NZ545853A (en) 2008-11-28
DE602004030131D1 (de) 2010-12-30
BRPI0414786A (pt) 2006-11-21
JP2007506685A (ja) 2007-03-22
US7621740B2 (en) 2009-11-24
EP1663154A4 (fr) 2006-12-13
AU2004273556B2 (en) 2010-12-02
ATE488226T1 (de) 2010-12-15
MXPA06003146A (es) 2006-08-31
CN1856318B (zh) 2010-05-26
RU2388482C2 (ru) 2010-05-10
US7205006B2 (en) 2007-04-17
US20070148226A1 (en) 2007-06-28
RU2006109188A (ru) 2007-10-27
KR20060069514A (ko) 2006-06-21
EP1663154A1 (fr) 2006-06-07
IL174206A0 (en) 2006-08-01
CN1856318A (zh) 2006-11-01
US20050069576A1 (en) 2005-03-31
WO2005027945A1 (fr) 2005-03-31
EP1663154B1 (fr) 2010-11-17
CA2538867A1 (fr) 2005-03-31

Similar Documents

Publication Publication Date Title
US7621740B2 (en) Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
CN101653537B (zh) 神经酰胺产生促进剂
KR20220159075A (ko) 피부모사 리포좀 및 보습효능을 포함하는 이의 용도
KR100905386B1 (ko) 생약추출물을 함유하는 아토피 피부용 한방화장료 조성물
US20110250239A1 (en) Pharmaceutical and/or cosmetic composition for treating the skin
JP3537878B2 (ja) 発毛抑制剤及びそれを含有する化粧料
KR100530843B1 (ko) 동충하초 추출물을 유효성분으로 포함하는 항염 조성물
KR20150050980A (ko) 윈터체리 추출물을 유효성분으로 포함하는 항염 화장료 조성물 또는 항염 피부 외용제
EP4529452B1 (fr) Formes posologiques pour l'administration topique de triterpènes pentacycliques
KR101322850B1 (ko) 박하잎 추출물, 밀싹 추출물 및 길경 추출물을 유효성분으로 포함하는 모공 축소 또는 피지분비 억제용 화장료 조성물
KR101512190B1 (ko) 경피 전달용 아미덤 조성물
KR101135193B1 (ko) 나노리포좀으로 안정화된 리소포스파티딜콜린과 노루풀 추출물을 함유하는 주름 개선용 화장료 조성물
JP2001261545A (ja) 肌荒れ防止用皮膚外用剤
JPH11255661A (ja) アトピー性皮膚炎用外用剤
KR101866518B1 (ko) 프로폴리스 추출물을 유효성분으로 함유하는 조갑진균증 무좀 개선용 크림 조성물
KR101035955B1 (ko) 정좌초 추출물을 유효성분으로 함유하는 아토피성 피부 개선용 화장료 조성물
KR102630567B1 (ko) 에이트 컴플렉스 함유물질에 따라 피부 흡수율 증진효과를 갖는 리포좀 조성물 및 이의 제조방법
KR102921758B1 (ko) 나노 수용화 커큐민을 함유하는 민감성 피부용 화장품 조성물
KR100853120B1 (ko) 나노리포좀에 안정화된 하고초 추출물을 함유하는 화장료 조성물
KR102617427B1 (ko) 안정성이 향상된 리기다 소나무 껍질 추출물 봉입 나노 입자 및 제조방법, 이를 함유하는 화장료 조성물
KR20070033133A (ko) 아토피 예방 및 치료용 피부외용제 조성물
JP2002068931A (ja) 外用組成物
KR20040067042A (ko) 생약추출물을 함유하는 항염효과를 갖는 화장료조성물
KR102071110B1 (ko) 독활 복합오일을 포함하는 항아토피성 약학 조성물
JP2003313116A (ja) 皮膚外用剤